CBD Life Sciences Inc.
OTC: CBDL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Lisa Anne Nelson
- Employees
- 3
- Headquarters
- Scottsdale, United States
- IPO year
- 2009
- Market cap
- $563.1K
- Website
- https://lbcbioscienceinc.com
Loading CBDL…
Loading profile data…Frequently asked questions about CBDL
What does CBD Life Sciences Inc. (CBDL) do?
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedi...
Where does CBDL trade?
CBD Life Sciences Inc. (CBDL) trades on the Other OTC.
What sector is CBDL in?
CBD Life Sciences Inc. (CBDL) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of CBD Life Sciences Inc.?
Lisa Anne Nelson is the chief executive officer of CBD Life Sciences Inc. (CBDL).
Where is CBD Life Sciences Inc. headquartered?
CBD Life Sciences Inc. is headquartered in United States.
Does CBDL pay a dividend?
CBD Life Sciences Inc. (CBDL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CBDL go public?
CBD Life Sciences Inc. (CBDL) completed its initial public offering in 2009.